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Summary
Objectives: The aim of this study was to describe a new porous titanium thyroplasty implant
that can be adjusted with a screw.
Material and methods: Retrospective study of 15 patients with unilateral vocal fold paralysis
undergoing type I thyroplasty under local anaesthesia. Each patient’s dysphonia and swal-
lowing disorders were evaluated both objectively and subjectively before and 3months after
thyroplasty.
Results: Speech and swallowing disorders were improved in all the cases, except when the
patients were suffering from severe associated neurological disorders (n = 3). The postoperative
complications were minor including a laryngeal edema treated by corticotherapy per os (n = 1)
and a superﬁcial cervical haematoma (n = 1).
Conclusions: This implant is easy to insert and the results show high tolerance of the biomaterial
and above all the improvement of functions comparable to other laryngeal implants.
. All
o
t
d
a
a© 2010 Elsevier Masson SAS
ntroduction
nilateral vocal fold paralysis is most often responsible for
eﬁcient glottic closure stemming from a defect in vocal
old closure. The paralyzed vocal fold placed in abduction
r in an intermediary position results in dysphonia, swal-
owing disorders, reduced coughing effectiveness, or even
hortness of breath, which may have a major effect on the
atient’s quality of life.
∗ Corresponding author. Tel.: +06 63 75 55 87.
E-mail address: marie.devos@chru-strasbourg.fr (M. Devos).
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Medialization of the vocal fold with a thyroid implant is
ne of the most widely employed surgical techniques for
reating glottic insufﬁciency. Isshiki et al. [1] described and
eveloped it beginning in 1974. The intervention consists in
cervicotomy placing an implant in the paraglottic space,
fter creating a cartilaginous window in the thyroid wing
type I thyroplasty). The vocal fold and the arytenoid process
re thus medialized, which allows better vocal fold closure
nd reduction of deﬁcient glottic closure.
Several implants have been described, each with its own
dvantages and disadvantages [2—7]. Based on our experi-
nce in the use of porous titanium in cervical surgery, we
ound it useful to develop a single-model implant that could
asily be directly adjusted in the patient including during
urgical revision.
served.
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Table 1 Description of patients.
Patient Sex Age Side Etiology Symptoms Time to 1st
thyroplasty
symptoms
(months)
Associated
nerve
involvement
Previous
treat-
ment
Complications
Voice Swallowing
1 M 72 Left Parapharyngeal
surgery for
schwannoma
Dysphonia Aspiration of
saliva
9.0
2 M 62 Left Carotid surgery
(endarterec-
tomy)
Dysphonia Aspiration of
liquids and
solids
3.0 IX, XI
3 M 76 Left Surgery for
malignant
tumor of the
pontocerebel-
lar
angle
Dysphonia Aspiration of
liquids and
solids
48.0 VII
4 M 54 Left Petrosectomy
for chondrosar-
coma
Dysphonia 96.0 VII, XII
5 F 74 Left Idiopathic Dysphonia Chronic cough:
aspiration of
saliva
12.0
6 F 73 Left Amyloses Dysphonia 60.0
7 M 82 Right Carotid surgery
(endarterec-
tomy)
Aphonia Aspiration of
liquids and
solids
3.0
8 M 66 Left Mediastinal
curettage for
bronchopul-
monary
carcinoma
Dysphonia Aspiration of
sparkling
liquids
8.0 Superﬁcial
hematoma
Review at 7
months to
tighten
implant
9 M 65 Left Mediastinal
curettage for
bronchopul-
monary
carcinoma
Dysphonia Aspiration of
liquids
0.23
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Table 1 (Continued)
Patient Sex Age Side Etiology Symptoms Time to 1st
thyroplasty
symptoms
(months)
Associated
nerve
involvement
Previous
treat-
ment
Complications
Voice Swallowing
10 M 53 Left Thyroid surgery
for papillary
carcinoma
Dysphonia 11.0
11 M 71 Left Mediastinal
compression
from
metastatic
adenopathy of
pulmonary
carcinoma
Dysphonia Aspiration of
liquids
Dysphagia
3.0 Laryngeal
edema
12 M 65 Right Mediastinal
curettage for
bronchopul-
monary
carcinoma
Dysphonia,
problems
coughing,
breathlessness
with exercise
Aspiration of
liquids
6.0
13 M 75 Right Mediastinal
curettage for
bronchopul-
monary
carcinoma
Dysphonia Aspiration of
liquids
0.5
14 F 82 Left Mediastinal
compression
from
metastatic
adenopathy of
breast
carcinoma
Dysphonia Aspiration of
liquids
10.0
15 F 78 Left Idiopathic Dysphonia Aspiration of
liquids
Inhalation
pneumopathy
8.0
M: male; F: Female.
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ment of sterile champs, the inferior and superior edges of
the thyroid cartilage, the cricoid cartilage, as well as the
cricothyroid membrane, are identiﬁed. After local anesthe-
sia, a 4- to 5-cm incision is made facing the inferior edgeThyroplasty for unilateral vocal fold paralysis
The objective of this study was to present a new implant
in porous titanium placed in a type I thyroplasty procedure in
15 patients with unilateral vocal fold paralysis. We describe
the surgical technique and the complications, and then ana-
lyze the patients’ progress in terms of voice and swallowing
disorders.
Material and methods
Study characteristics
This phase I study was conducted at the Strasbourg Uni-
versity Hospitals (HUS No. 3097) and was designed to assess
the tolerance and effectiveness of the implant, a perfectly
biocompatible implant made solely of titanium T40.
The study was conducted after approval of the AFSSAPS
and obtaining approval from the Ethical Committee. The
clinical follow-up of the patients was conducted for 3 years
after the procedure.
Patient characteristics
Fifteen patients (n = 15) who underwent a type I thyroplasty
with an adjustable implant in porous titanium were included
in the study between May 2006 and May 2009. All of them
presented unilateral vocal fold paralysis causing invalidating
dysphonia, some accompanied by aspiration.
The indication for thyroplasty was decided (i) after
failure of speech rehabilitation lasting at least 3 months
(n = 11) or (ii) in an emergency setting because of severe
aspiration after thoracic surgery (n = 4).
The 15 patients were operated on under local anesthesia
by three different surgeons, except for one patient who had
a thyroidectomy under general anesthesia in the same sur-
gical time. This series included 11 males and four females
ranging from 53 to 82 years of age (median: 72 years).
Patient age, the etiology and side of vocal fold paralysis,
the preoperative laryngeal signs, associated involvement of
cranial nerves, time between the onset of the ﬁrst clini-
cal symptoms and the intervention, any treatments before
the thyroplasty, and the postoperative complications are
reported in Table 1.
The median follow-up of the study was 19months (range:
2—39months).
Presentation of the implant
The implantable device (ThyroprotipTM, manufactured by
PROTIP, Strasbourg, France) comprised two parts: (i) a tri-
angular thyroplasty implant, made of welded titanium T40
beads (granulometry, 400—500m) and (ii) a plate to main-
tain the implant with a screw (Fig. 1). The tail of the screw
is held in the insert of the porous part and the head has a
groove for the screwdriver.An ancillary gauge is used to identify the position and
shape of the cartilaginous window (Fig. 2).
The implant and the ancillary gauge are available in two
sizes for males and females. The sizes are reported in Fig. 3.
A 40-mm screw is used to adjust the implant.
F
gFigure 1 Implant and plate.
The implant has had the CE mark since December 2008
nd is now marketed. It currently costs 525D before VAT.
urgical technique
he surgery was performed under local anesthetic (lidocaine
% with or without adrenaline), associated with remifentanil
edation maintained via syringe pump infusion or in target
ontrolled intravenous anesthesia mode. The patient, in the
orsal decubitus position, the head rotated to the side oppo-
ite the thyroplasty, is placed on 3 L of O2/min, monitored
y an anesthesiologist. After skin disinfection and place-igure 2 Sizing the cartilage window using the ancillary
auge.
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1Figure 3 Component s
f the thyroid cartilage, extending 1 cm beyond the midline
f the opposite side. The sternohyoid muscle is retracted
nd the thyrohyoid muscle is resected to expose the entire
hyroid cartilage, including the midline. When the thyroid
amina is exposed, its posterior edge is elevated with a
illis-type hook to improve exposure and identify the infe-
ior tubercle of the thyroid cartilage. The cartilage window
s situated after taking the measurements with the ancillary
auge. The ancillary fork is placed against the inferior edge
f the thyroid cartilage, on either side of the inferior thyroid
ubercle. The superior edge of this gauge matches the level
f the vocal fold. The contour of the window is traced on
he outer perichondrium, following the outline of the gauge
13× 6mm for males, 11× 5mm for females) (Fig. 2).
The window is cut out using a burr, until the inner
erichondrium is visualized. The inner perichondrium is cir-
umferentially elevated over approximately 3mm around
he window using a foam elevator, then incised along a
edian anteroposterior axis.
The thyroplasty implant is inserted through the window
ut in the thyroid lamina using forceps. The plate is placed,
nserting the screw in the hole; then it is turned 90◦ so that
he ends of the plate can be inserted under the inferior and
uperior cartilage edges of the window that has been ele-
ated from the inner perichondrium. It thus covers the inner
ide of the cartilage because its length is greater than the
eight of the window.
The surgeon asks the patient to pronounce the vowel
‘a’’ at different heights and intensities so as to provide
deal implant adjustment. A clockwise rotation of the screw
ncreases the gap between the active part of the implant and
he plate, thus favoring vocal fold tension. A counterclock-
ise rotation reduces the gap and vocal fold tension. When
he optimal adjustment is obtained, the screwdriver is with-
rawn, with the adjustment and the screw maintained with
o additional maneuver. The subhyoid muscles are brought
p
a
d
‘
lccording to patient sex.
o the median line and the cutaneous suture is stitched after
rainage.
Postoperatively, stage I paracetamol-type antalgics, 1 g
our times a day, were systematically given. Three patients
ad per os antibiotic therapy (amoxicillin—clavulanic acid
or 6 days), one of whom also had associated per os
orticotherapy (prednisolone 40mg). Two patients had
ntra- and postoperative IV corticotherapy (one 60-mg
ose of methylprednisolone), associated with inhaled
orticotherapy (betamethasone, 1mL) for one of them.
riteria of analysis
he pretherapy workup included an examination of
he cranial nerves, a complete ENT examination with
asoﬁbroscopic assessment of swallowing, and a video-
aryngostroboscopy. Two patients did not have a clear
ecent cause for vocal fold paralysis and therefore
nderwent cervicothoracic CT extending to the base
f the skull without and with injection of contrast
roduct.
The day before the intervention, a subjective percep-
ive evaluation of the voice by the physician and/or speech
athologist (GRBAS, Grade Roughness Breathlessness Asthe-
ia Strength scale) and the patient (VHI, Voice Handicap
ndex 10) as well as a computerized recording for objective
nalysis were carried out. The vocal recording took place in
quiet room, with an integrated stereo Edirol R-09HR 24-
it 96-kHz Wave microphone, sampled at 44.1 kHz, placed
5 cm from the patient’s mouth. The patient was asked to
ronounce the vowel ‘‘a’’ three times and hold it as long
s possible at a comfortable frequency and intensity for the
uration of an exhalation, then to read the short phrase
‘c’est une affaire intéressante, qu’en pensez-vous ? Il faut
a faire sans aucun regret’’, then to read the Roman de
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Renart text ‘‘Comment Renart emporta de nuit les bacons
d’Ysengrin ?’’
The aerodynamic parameter retained was the maximum
phonation time (MPT).
The acoustic parameters studied were the fundamental
frequency (Fo), jitter (variation in Fo from cycle to cycle),
shimmer (variation in amplitude from cycle to cycle), and
the noise-to-harmonic ratio (N/H ratio). The software used
to analyze the objective data was Praat®.
Given the low number of subjects included in the study,
nonparametric tests were used for paired series so as to com-
pare these pre- and postoperative characteristics (MPT, Fo,
jitter, shimmer, VHI, and GRBAS) in each subject 3months
after the intervention. The sign test and the Wilcoxon test
for paired series were used in the statistical analysis of MPT,
Fo, jitter, shimmer, and VHI. To interpret the GRBAS, we
used a binomial test (with a reference probability at 0.5).
The signiﬁcance level was set at 0.05.
The patients were followed up at 15 days, 1, 3, 6, 12,
and 18months after the thyroplasty for a clinical examina-
tion and voice evaluation and swallowing assessment with
a nasoﬁbroscopy. At 3months, a videolaryngostroboscopy, a
cervical CT with no contrast product injection, a new vocal
recording by the same physician and/or speech pathologist
with subjective evaluation on the GRBAS and VHI 10 scales
were added.
Results
Immediate postoperative morbidity
No major immediate postoperative complications were
found. Two minor complications (12.5%) appeared in the
immediate postoperative period: a superﬁcial cervical
haematoma that did not require surgical revision and a
laryngeal edema with no major dyspnea that regressed with
per os corticotherapy.
We noted no beneﬁt from systematic postoperative
antibiotic therapy in preventing complications.
No implant extrusion was noted, although the study’s
follow-up was short.
In one patient, the pressure obtained on the vocal fold
was insufﬁcient after complete tightening of the screw. The
implant had to be impacted and maintained with transcarti-
lage nonresorbable suture to obtain satisfactory phonation.
The mean hospital stay was 2.2 days (range: 1—8days):
50% of the patients (n = 8) were able to return home on
day 1 and 33% (n = 6) on day 2. The patient who presented
postoperative laryngeal edema returned home on day 6.
This patient, in poor general health, died 3months after
the thyroplasty from progression of the causative malignant
disease. The patient who underwent associated thyroidec-
tomy left the hospital on day 8.
One patient was lost to follow-up after thyroplasty
because his general health worsened due to preexisting con-
gestive heart failure.Analysis of voice and speech
In all cases, the patients declared immediate voice improve-
ment after the thyroplasty. In two patients, the phonation
s
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p
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esults were insufﬁcient: one with major vocal fold atro-
hy secondary to pneumogastric nerve resection and the
ther because of insufﬁcient medialization of the implant
onﬁrmed by clinical and radiological examination. This
atient underwent revision under local anesthesia 7months
fter the initial intervention to further tighten the implant
crew and obtain better closure of the vocal folds. Despite
his surgery and the improvement noted in videolaryn-
ostroboscopy, this patient’s voice remained very breathy.
he other patients’ videolaryngostroboscopies (n = 13), done
months after the thyroplasty, all showed good vocal fold
losure. In one case, the paralyzed vocal fold spontaneously
eturned to function 12months after the thyroplasty. The
mplant left in place is well tolerated by the patient.
All the follow-up cervical CTs done 3months after thyro-
lasty conﬁrmed that the implant was properly placed. No
mplant displacement was observed.
The statistical analysis of the study parameters showed
hat the difference between pre- and postoperative GRBAS,
HI, and MPT values were signiﬁcant. For shimmer, the
ifference was not signiﬁcant. For the other values (Fo,
/H ratio, and jitter), the two tests (the sign test and the
ilcoxon test) did not agree: we only retained the less
avorable of the two and considered that the pre- and post-
perative values did not present a signiﬁcant difference
Table 2).
nalysis of swallowing
efore thyroplasty, 75% of the patients (n = 12) presented
ither moderate (n = 6) or severe (n = 6) aspiration. Three
atients were fed via gastrostomy tube. Nine patients (75%)
o longer presented aspiration after thyroplasty, including
he three who had a gastronomy tube, who were weaned
rom the gastrostomy tube and were able to take food nor-
ally.
The three patients whose aspiration was not improved
y thyroplasty presented associated neurological impair-
ent following carotid surgery (n = 1) and skull base surgery
n = 2).
iscussion
urgical treatment of recurrent unilateral paralysis of the
ocal folds is indicated in cases of life-threatening aspiration
nd invalidating dysphonia not improved by speech therapy
8,9]. The two most widely used surgical techniques are
ntrafold autologous fat or synthetic material injection or
ype I thyroplasty, with or without arytenoid adduction (type
II thyroplasty). The latter consists in forwardly attaching the
uscle apophysis of the arytenoid cartilage to the thyroid
amina so as to internally rotate the arytenoid and medial-
ze the ipsilateral vocal fold. Thyroplasty has the advantage
f being performed under local anesthesia, allowing the
urgeon to adapt implant size and placement to the vocal
esult and to increase the risks related to general anesthe-
ia in often fragile patients. The choice between these two
echniques should be adapted to the clinical context; thyro-
lasty is generally preferred in cases of insufﬁcient adipose
anicle, contraindications to general anesthesia, substantial
ocal fold atrophy, and permanent recurrent paralysis [8].
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Table 2 Analysis of GRBAS score, objective parameters, and pre- and postoperative VH (M3) (n = 8 for GRBAS, n = 10 for TMP,
n = 14 for VHI, n = 5 for jitter, shimmer, Fo, N/H ratio).
Preoperative 3 months P-value
Binomial
G Mean 2.5 0.9 0.008
Range 2—3 0—2
R Mean 2.6 1.3 0.008
Range 2—3 0—3
B Mean 2 0 0.008
Range 0—3 0—0
A Mean 2.4 0.5 0.008
Range 1—3 0—1
A Mean 1.8 0.3 0.008
Range 0—3 0—1
Wilcoxon Signs
MPT (s) Mean 4.1 9.2 0.005 0.002
Range 2—10 6—14
Fo (Hz) Mean 160.6 191.5 0.043 0.062
Range 133—209.8 170.1—262.3
Jitter (%) Mean 2.7 1.3 0.043 0.062
Range 1.8—4.4 0.5—2.6
Shimmer (%) Mean 14.9 11.8 0.225 1.000
Range 13—17.8 7.6—18.6
N/H ratio Mean 5.1 11.6 0.043 0.062
Range 1.6—13 4.3—17
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Range 10—36
Other procedures for medializing the vocal fold are pro-
osed.
The most frequently encountered complications dur-
ng thyroplasty are, for all types of implant combined
Gore-tex, silicone, titanium): dyspnea with intralaryn-
eal haematoma or edema (0.8—6.5%), with at times
racheotomy required (1.5%), cervical haematoma (1%),
nfection of the approach (1%), and early or delayed extru-
ion of the implant (1.3—11.1%) [4,9—13]. Whatever type
f implant is used, in cases of substantial posterior glot-
al leakage, thyroplasty may actually be insufﬁcient and
hould be completed by arytenoid adduction [3,9]. With
ontgomery implants, intraoperative complications such
s the impossibility of stabilizing the posterior part of
he implant or cartilage fracture located under the carti-
age window have been encountered [13]. Postoperatively,
ases of posterior dislodgement of the implant have been
oted.
We found it advantageous to develop an implant that
ould present less risk of extrusion, easy placement and
djustment, adapted to each patient, with surgical revi-
ion facilitated. To reduce the risk of extrusion, we chose
material that would be perfectly integrated into the sur-
ounding tissue environment: porous titanium. The porosity
f titanium, a biocompatible material, allows the implant
o be colonized by surrounding cells, which should progres-
ively ﬁll the micropores [14]. Better ﬁxation is obtained,
he healing time is shorter, and cell adhesion is better
han with solid titanium. Screw adjustment has several
u
e
t
b15.1 0.001 < 0.0001
0—33
dvantages: multiple manipulations of phantoms or implants
re avoided and repeated injury to the internal laryngeal
tructures is prevented. Furthermore, it facilitates surgical
evision in cases of insufﬁcient medialization: the implant
s left in place and medialization is remedied by tightening
he screw. The single ancillary instrument aids the surgeon
n locating and drawing the cartilage window, simplifying
lacement.
The objective of this study was to present the prelimi-
ary results of thyroplasty performed with the new porous
itanium implant.
Like the other thyroplasty implants, overall voice
mprovement was observed immediately after the surgery.
xcept for two patients whose general or local condi-
ion was mediocre, all experienced long-term improve-
ent.
The signiﬁcant VHI 10 improvement shows that patients’
uality of life was improved. The VHI 10 is one of the
ost reliable self-assessment questionnaires for dyspho-
ia. It is a short version of the VHI, which requires less
ime to complete, while preserving validity for assessing
voice handicap [15]. This version was preferred in
his study because of the median age of the patients
71.5 years).The signiﬁcant postoperative increase in the GRBAS score
nderlines the subjective improvement of dysphonia by an
xperienced listener. The signiﬁcant increase in MPT reﬂects
he reduction in glottal leakage, also observed with stro-
oscopy. Interpretation of the other objective data (jitter,
CC
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shimmer, Fo) is delicate because of the insufﬁcient num-
ber of patients recorded: only ﬁve patients underwent vocal
recordings both pre- and postoperatively. These encouraging
results support pursuing the study so as to include a greater
number of patients.
It would have been useful to be able to compare the
objective vocal results and apply the Basic Protocol for
Functional Assessment of Voice Pathology elaborated by the
European Laryngology Society [16]. It includes:
• an analysis of voice quality with a perceptive analy-
sis by the physician (GRBAS scale), self-assessment by
the patient (Voice Handicap Index), and measurement of
objective acoustic parameters (Fo, jitter, shimmer, N/H
ratio, and phonetogram);
• an analysis of laryngeal function with measurement of
aerodynamic parameters (MPT, air ﬂow rate during phona-
tion, subglottic pressure);
• videolaryngostroboscopy [17,18].
The recordings were made 3months after the thyro-
plasty because we noted that in most cases voice results
at 1month did not agree with those found at 3, 6, and
12months, although they most often remain stable after
3months. Gorham et al. found that postoperative voice fold
edema and haematoma could persist 1—3months after the
intervention [10]. Hartl et al. also noted a deterioration in
voice quality in the ﬁrst few months, with stabilization after
approximately 3months [19].
As for other implants, swallowing impairment was clearly
improved, except for patients presenting severe associated
neurological problems [20].
In 13.3% of the cases (n = 2), the voice result was
not satisfactory. The patients presented posterior glottal
leakage (n = 2) persisting after thyroplasty. We proposed
an additional procedure: fat injection, arytenoid adduc-
tion, or revision for medialization of the implant by
tightening the screw. One of the patients with glot-
tal leakage underwent revision under local anesthesia
to tighten the implant screw. Despite visible improve-
ment on the videolaryngostroboscopy, posterior glottal
leakage persisted, with a high degree of breathiness. In
this patient, we are planning complementary fat injec-
tion. Arytenoid adduction or fat injection could improve
the second patient’s condition, major atrophy of the
vocal fold secondary to recurrent paralysis. We are
hesitating between the minimally invasive fat injection
technique and the other solution, arytenoid adduction,
probably more effective but which requires a new cervical
approach.
Conclusion
Thyroplasty with an adjustable implant in porous titanium
seems to us to be a useful option in the treatment of
vocal fold paralysis. Placing the implant is simple and the
results show very good tolerance to the biomaterial. The
functional results are comparable to the other vocal fold
implants.
[211
onﬂict of interest statement
. Debry, P. Schultz: scientiﬁc advisors for PROTIP.
M. Devos, F. Guilleré: none.
eferences
[1] Isshiki N, Moritam M, Okamura H, et al. Thyroplasty as
a new phonosurgical technique. Acta Otolaryngol 1974;78:
451—7.
[2] Tucker HM, Wanamaker J, Trott M, et al. Complications of
laryngeal framework surgery (phonosurgery). Laryngoscope
1993;103:525—8.
[3] Netterville JM, Stone RE, Luken SE, et al. Silastic medialization
and arytenoid adduction: the Vanderbilt experience. Ann Otol
Rhinol Laryngol 1993;102:413—24.
[4] Giovanni A, Gras R, Grini MN, et al. Médialisation de
la corde vocale paralysée par un implant de polyté-
traﬂuoroéthylène expansé (Gore-tex). Ann Otolaryngol Chir
Cervicofac 1997;114:158—64.
[5] Cummings CW, Purcell LL, Flint PW. Hydroxylapatite laryngeal
implants for medialization. Preliminary report. Ann Otol Rhinol
Laryngol 1993;102:843—51.
[6] Stasney CR, Beaver ME, Rodriguez M. Minifenestration type
I thyroplasty using an expanded polytetraﬂuoroethylene
implant. J Voice 2001;15:151—7.
[7] Schneider B, Denk DM, Bigenzahn W. Functional results
after external vocal fold medialization thyroplasty with
the titanium vocal fold medialization implant. Laryngoscope
2003;113:628—34.
[8] Recommandations SFORL III. Les paralysies récurrentielles de
l’adulte. 2002.
[9] Abraham MT, Gonen M, Kraus DH. Complications of type
I thyroplasty and arytenoid adduction. Laryngoscope
2001;111:1322—9.
10] Gorham MM, Avidano MA, Crary MA, et al. Laryngeal recovery
following type I thyroplasty. Arch Otolaryngol Head Neck Surg
1998;124:739—42.
11] Schneider B, Denk DM, Bigenzahn W. Acoustic assess-
ment of the voice quality before and after medialization
thyroplasty using the titanium vocal fold medialization
implant (TVFMI). Otolaryngol Head Neck Surg 2003;128:
815—22.
12] Mc Culloch TM, Hoffman HT, Andrews BT, et al. Arytenoid
adduction combined with gore-tex medialization thyroplasty.
Laryngoscope 2000;110:1306—11.
13] Nouwen J, Hans S, De Mones E, et al. Thyroplasty type I without
arytenoid adduction in patients with unilateral laryngeal nerve
paralysis: the Montgomery implant versus the gore-tex implant.
Acta Otolaryngol 2004;124:732—8.
14] Brentel AS, Vasconcellos LMR, Oliveira MV, et al. Histomor-
phometric analysis of pure titanium implants with porous
surface versus rough surface. J Appl Oral Sci 2006;14:
213—8.
15] Rosen CA, Lee AS, Osborne J, et al. Development and
validation of the Voice Handicap Index 10. Laryngoscope
2004;114:159—56.
16] Dejonckere PH, Bradley P, Clemente P, et al. A basic proto-
col for functional assessment of voice pathology, especially
for investigating the efﬁcacy of (phonosurgical) treatments
and evaluating new assessment techniques. Eur Arch Otorhi-
nolaryngol 2001;258:77—82.
17] Hartl DM, Hans S, Crevier Buchman L, et al. Méthodes actuelles
d’évaluation des dysphonies. Ann Otolaryngol Chir Cervicofac
2005;122:163—72.
2[
[
[20] Laccourreye O, El Sharkawy L, Holsinger C, et al. Thyroplasty12
18] Giovanni A, Révis J, Ghio A. Le phoniatre face à l’analyse
instrumentale des dysphonies. Rev Laryngol Otol Rhinol
2009;130:3—10.
19] Hartl DM, Brasnu D. Les paralysies récurrentielles : connaissan-
ces actuelles et traitements. Ann Otolaryngol Chir Cervicofac
2000;117:60—84.M. Devos et al.type I with Montgomery implant among native French language
speakers with unilateral laryngeal nerve paralysis. Laryngo-
scope 2005;115:1411—7.
